Nanoparticle Drug Delivery Systems for α-Mangostin
Nasrul Wathoni,1 Agus Rusdin,1,2 Keiichi Motoyama,3 I Made Joni,4 Ronny Lesmana,5 Muchtaridi Muchtaridi6 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia; 2Department of Pharmacy, Faculty of Sports and Health, Univers...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5f10ec62dd944778a7d5584103c3cc13 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5f10ec62dd944778a7d5584103c3cc13 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5f10ec62dd944778a7d5584103c3cc132021-12-02T05:12:08ZNanoparticle Drug Delivery Systems for α-Mangostin1177-8903https://doaj.org/article/5f10ec62dd944778a7d5584103c3cc132020-04-01T00:00:00Zhttps://www.dovepress.com/nanoparticle-drug-delivery-systems-for-alpha-mangostin-peer-reviewed-article-NSAhttps://doaj.org/toc/1177-8903Nasrul Wathoni,1 Agus Rusdin,1,2 Keiichi Motoyama,3 I Made Joni,4 Ronny Lesmana,5 Muchtaridi Muchtaridi6 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia; 2Department of Pharmacy, Faculty of Sports and Health, Universitas Negeri Gorontalo, Gorontalo 96128, Indonesia; 3Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan; 4Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia; 5Department of Anatomy, Physiology and Biology Cell, Faculty of Medicine, Universitas Padjadjaran, Sumedang 45363, Indonesia; 6Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, IndonesiaCorrespondence: Muchtaridi MuchtaridiBandung-Sumedang KM 21, Sumedang, West Java 45363, IndonesiaTel +622 842 888888 3510Fax +622 842 888888Email muchtaridi@unpad.ac.idAbstract: α-Mangostin, a xanthone derivative from the pericarp of Garcinia mangostana L., has numerous bioactivities and pharmacological properties. However, α-mangostin has low aqueous solubility and poor target selectivity in the human body. Recently, nanoparticle drug delivery systems have become an excellent technique to improve the physicochemical properties and effectiveness of drugs. Therefore, many efforts have been made to overcome the limitations of α-mangostin through nanoparticle formulations. Our review aimed to summarise and discuss the nanoparticle drug delivery systems for α-mangostin from published papers recorded in Scopus, PubMed and Google Scholar. We examined various types of nanoparticles for α-mangostin to enhance water solubility, provide controlled release and create targeted delivery systems. These forms include polymeric nanoparticles, nanomicelles, liposomes, solid lipid nanoparticles, nanofibers and nanoemulsions. Notably, nanomicelle modification increased α-mangostin solubility increased more than 10,000 fold. Additionally, polymeric nanoparticles provided targeted delivery and significantly enhanced the biodistribution of α-mangostin into specific organs. In conclusion, the nanoparticle drug delivery system could be a promising technique to increase the solubility, selectivity and efficacy of α-mangostin as a new drug candidate in clinical therapy.Keywords: Garcinia mangostana, solubility, controlled release, targeted delivery, nanoparticle formulations, physicochemical propertiesWathoni NRusdin AMotoyama KJoni IMLesmana RMuchtaridi MDove Medical Pressarticlegarcinia mangostanasolubilitycontrolled releasetargeted deliverynanoparticle formulationsphysicochemical propertiesMedical technologyR855-855.5Chemical technologyTP1-1185ENNanotechnology, Science and Applications, Vol Volume 13, Pp 23-36 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
garcinia mangostana solubility controlled release targeted delivery nanoparticle formulations physicochemical properties Medical technology R855-855.5 Chemical technology TP1-1185 |
| spellingShingle |
garcinia mangostana solubility controlled release targeted delivery nanoparticle formulations physicochemical properties Medical technology R855-855.5 Chemical technology TP1-1185 Wathoni N Rusdin A Motoyama K Joni IM Lesmana R Muchtaridi M Nanoparticle Drug Delivery Systems for α-Mangostin |
| description |
Nasrul Wathoni,1 Agus Rusdin,1,2 Keiichi Motoyama,3 I Made Joni,4 Ronny Lesmana,5 Muchtaridi Muchtaridi6 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia; 2Department of Pharmacy, Faculty of Sports and Health, Universitas Negeri Gorontalo, Gorontalo 96128, Indonesia; 3Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan; 4Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia; 5Department of Anatomy, Physiology and Biology Cell, Faculty of Medicine, Universitas Padjadjaran, Sumedang 45363, Indonesia; 6Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, IndonesiaCorrespondence: Muchtaridi MuchtaridiBandung-Sumedang KM 21, Sumedang, West Java 45363, IndonesiaTel +622 842 888888 3510Fax +622 842 888888Email muchtaridi@unpad.ac.idAbstract: α-Mangostin, a xanthone derivative from the pericarp of Garcinia mangostana L., has numerous bioactivities and pharmacological properties. However, α-mangostin has low aqueous solubility and poor target selectivity in the human body. Recently, nanoparticle drug delivery systems have become an excellent technique to improve the physicochemical properties and effectiveness of drugs. Therefore, many efforts have been made to overcome the limitations of α-mangostin through nanoparticle formulations. Our review aimed to summarise and discuss the nanoparticle drug delivery systems for α-mangostin from published papers recorded in Scopus, PubMed and Google Scholar. We examined various types of nanoparticles for α-mangostin to enhance water solubility, provide controlled release and create targeted delivery systems. These forms include polymeric nanoparticles, nanomicelles, liposomes, solid lipid nanoparticles, nanofibers and nanoemulsions. Notably, nanomicelle modification increased α-mangostin solubility increased more than 10,000 fold. Additionally, polymeric nanoparticles provided targeted delivery and significantly enhanced the biodistribution of α-mangostin into specific organs. In conclusion, the nanoparticle drug delivery system could be a promising technique to increase the solubility, selectivity and efficacy of α-mangostin as a new drug candidate in clinical therapy.Keywords: Garcinia mangostana, solubility, controlled release, targeted delivery, nanoparticle formulations, physicochemical properties |
| format |
article |
| author |
Wathoni N Rusdin A Motoyama K Joni IM Lesmana R Muchtaridi M |
| author_facet |
Wathoni N Rusdin A Motoyama K Joni IM Lesmana R Muchtaridi M |
| author_sort |
Wathoni N |
| title |
Nanoparticle Drug Delivery Systems for α-Mangostin |
| title_short |
Nanoparticle Drug Delivery Systems for α-Mangostin |
| title_full |
Nanoparticle Drug Delivery Systems for α-Mangostin |
| title_fullStr |
Nanoparticle Drug Delivery Systems for α-Mangostin |
| title_full_unstemmed |
Nanoparticle Drug Delivery Systems for α-Mangostin |
| title_sort |
nanoparticle drug delivery systems for α-mangostin |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/5f10ec62dd944778a7d5584103c3cc13 |
| work_keys_str_mv |
AT wathonin nanoparticledrugdeliverysystemsforalphamangostin AT rusdina nanoparticledrugdeliverysystemsforalphamangostin AT motoyamak nanoparticledrugdeliverysystemsforalphamangostin AT joniim nanoparticledrugdeliverysystemsforalphamangostin AT lesmanar nanoparticledrugdeliverysystemsforalphamangostin AT muchtaridim nanoparticledrugdeliverysystemsforalphamangostin |
| _version_ |
1718400532598489088 |